• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载紫杉醇的甘油棕榈酸酯纳米粒:体外释放和细胞毒性活性。

Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.

机构信息

Centre for Post Graduate Studies and Research, New Drug Delivery Systems laboratory, Pharmacy Department, M S University of Baroda, Vadodara, Gujarat, India. vikram.

出版信息

J Drug Target. 2009 May;17(4):304-10. doi: 10.1080/10611860902737938.

DOI:10.1080/10611860902737938
PMID:19255897
Abstract

Solid lipid nanoparticles (SLNs) of paclitaxel using glyceryl palmitostearate (GPS) as matrix were prepared by modified hot homogenization method. The SLNs were characterized for mean particle size, percent entrapment efficiency, and zeta potential, which were found to be 207 nm, 96.26%, and -28.26 mV, respectively. Transmission electron microscopic studies revealed that the prepared SLNs were of spherical shape. Drug retarding efficiency of the lipid (GPS) was better in pH 7.4 compared with pH 3.5. The release profile showed tendency to follow Higuchi diffusion pattern in both the media. Chemosensitivity assay carried out using B16F10 cell lines showed that antiproliferative activity of paclitaxel was not hindered because of encapsulation.

摘要

采用改良的热熔匀化法制备以甘油棕榈酸硬脂酸酯(GPS)为基质的紫杉醇固体脂质纳米粒(SLNs)。对 SLNs 的平均粒径、包封率和 Zeta 电位进行了表征,分别为 207nm、96.26%和-28.26mV。透射电子显微镜研究表明,所制备的 SLNs 呈球形。脂质(GPS)在 pH7.4 时的药物延缓效率优于 pH3.5。在两种介质中,释放曲线均呈现出符合 Higuchi 扩散模式的趋势。使用 B16F10 细胞系进行的化疗敏感性试验表明,紫杉醇的抗增殖活性并未因包封而受到阻碍。

相似文献

1
Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.载紫杉醇的甘油棕榈酸酯纳米粒:体外释放和细胞毒性活性。
J Drug Target. 2009 May;17(4):304-10. doi: 10.1080/10611860902737938.
2
Studies on paclitaxel-loaded glyceryl monostearate nanoparticles.紫杉醇载甘油单硬脂酸酯纳米粒的研究。
J Microencapsul. 2009 Sep;26(6):471-8. doi: 10.1080/02652040802379902.
3
Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.紫杉醇负载的空间稳定固体脂质纳米粒的制备、表征及体外细胞毒性
Biomaterials. 2007 Apr;28(12):2137-46. doi: 10.1016/j.biomaterials.2007.01.014. Epub 2007 Jan 10.
4
Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.使用改良溶剂注入技术制备的紫杉醇脂质纳米粒的表征及体外评价
Pharmazie. 2009 May;64(5):301-10.
5
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.疏水改性的壳聚糖二醇纳米颗粒作为紫杉醇的载体
J Control Release. 2006 Mar 10;111(1-2):228-34. doi: 10.1016/j.jconrel.2005.12.013. Epub 2006 Feb 3.
6
Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.载紫杉醇的聚(N-乙烯基吡咯烷酮)-b-聚(ε-己内酯)纳米粒的制备及其体内抗肿瘤活性。
J Control Release. 2010 Mar 19;142(3):438-46. doi: 10.1016/j.jconrel.2009.11.002. Epub 2009 Nov 5.
7
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.通过基于胆酸钠 - 磷脂酰胆碱的混合胶束负载胰岛素的固体脂质纳米粒:制备与表征
Int J Pharm. 2007 Aug 1;340(1-2):153-62. doi: 10.1016/j.ijpharm.2007.03.009. Epub 2007 Mar 12.
8
In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.负载紫杉醇的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒对喉癌细胞的体外评价
Anticancer Drugs. 2009 Oct;20(9):807-14. doi: 10.1097/CAD.0b013e328330c811.
9
Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel.水溶胀性透明质酸缀合物的合成、表征及其作为紫杉醇载体的意义。
Int J Pharm. 2010 Jul 15;394(1-2):154-61. doi: 10.1016/j.ijpharm.2010.04.041. Epub 2010 May 11.
10
Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.紫杉醇、依他硝唑及紫杉醇+依他硝唑纳米粒对体外缺氧人肿瘤细胞的放射增敏作用
Biomaterials. 2007 Sep;28(25):3724-30. doi: 10.1016/j.biomaterials.2007.04.032. Epub 2007 May 3.

引用本文的文献

1
Enhancing hair regeneration: Recent progress in tailoring nanostructured lipid carriers through surface modification strategies.促进毛发再生:通过表面修饰策略定制纳米结构脂质载体的最新进展。
ADMET DMPK. 2024 Jul 20;12(3):431-462. doi: 10.5599/admet.2376. eCollection 2024.
2
Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement.用于癌症治疗的脂质药物载体:对淋巴靶向、P-糖蛋白、CYP3A4调节及生物利用度提高的深入了解
Adv Pharm Bull. 2020 Sep;10(4):524-541. doi: 10.34172/apb.2020.064. Epub 2020 Aug 9.
3
Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies.
通过分散聚合法制备的基于聚丙交酯的载紫杉醇纳米颗粒:表征、癌细胞系评估及初步生物分布研究
J Pharm Sci. 2014 Aug;103(8):2546-55. doi: 10.1002/jps.24061. Epub 2014 Jun 24.
4
Paclitaxel Nano-Delivery Systems: A Comprehensive Review.紫杉醇纳米递送系统:综述
J Nanomed Nanotechnol. 2013 Feb 18;4(2):1000164. doi: 10.4172/2157-7439.1000164.